Previous Article | Next Article ![]()
Journal of Clinical Microbiology, 12 1997, 3098-3103, Vol 35, No. 12
M Gabbott, YE Cossart, A Kan, M Konopka, R Chan and BR Rose
This study provides the first systematic evaluation of papillomavirus type
and viral mutation occurring during the course of juvenile-onset recurrent
respiratory papillomatosis. One hundred ninety-nine consecutive papillomas
excised from 47 children between 1981 and 1996 at The New Children's
Hospital in Sydney, Australia, were tested for human papillomavirus (HPV)
DNA by PCR. PCR products from the viral upstream regulatory region (URR)
enhancer were sequenced, and variation was related to clinical variables.
Forty-four of the 47 children had HPV-induced papillomas, with type 11
accounting for 24 (55%) and type 6 accounting for 19 (43%); one (2%) was
positive for either type 6 or 11. Overall, 183 (98%) of the 186 samples
with amplifiable DNA were HPV positive. There was no change in HPV type
over time and no statistically significant association between HPV type and
disease aggressiveness. One novel, large-scale URR duplication was
identified in an HPV type 11 isolate in the last of a series of six
papillomas examined and the first from the bronchus. However, the
duplication was not found in HPV type 11 isolates from the associated
pulmonary carcinoma and its metastases in other organs. Three of 14 URR
point mutations coincided with transcription factor binding sites, but
there were no obvious associations with clinical course. Chi-square and
multiple linear regression analyses of clinicopathological variables
revealed early age at diagnosis (less than 4 years) as an independent
predictor of aggressive disease (P < 0.001). A bimodal distribution of
the age at diagnosis was noted, with peaks at 2 and 11 years of age.
Copyright © 1997 by the American Society for Microbiology. All rights reserved.
Human papillomavirus and host variables as predictors of clinical course in patients with juvenile-onset recurrent respiratory papillomatosis [In Process Citation]
Department of Infectious Diseases, The University of Sydney, New South Wales, Australia.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|